Black, J. D., Lopez, S., Cocco, E., Bellone, S., Altwerger, G., Schwab, C. L., . . . Santin, A. D. (2015). PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas. Br J Cancer.
Dyfyniad Arddull ChicagoBlack, Jonathan D., et al. "PIK3CA Oncogenic Mutations Represent a Major Mechanism of Resistance to Trastuzumab in HER2/neu Overexpressing Uterine Serous Carcinomas." Br J Cancer 2015.
Dyfyniad MLABlack, Jonathan D., et al. "PIK3CA Oncogenic Mutations Represent a Major Mechanism of Resistance to Trastuzumab in HER2/neu Overexpressing Uterine Serous Carcinomas." Br J Cancer 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.